About Simon
Simon is a genuine real estate investment that is accepted as true with a commitment to ownership of major destinations for shopping, dining, entertainment and combined uses and a corporate S
About QuestCap Inc.
QuestCap Inc. (CSE: QSC; FRA: 34C1) is for disruptive technologies, innovative inventions and exclusive partnerships to help combat COVID-19 and generate significant risk-adjusted yields for investors Specifically, QuestCap provides investors with diversified investment in the COVID- 19 medical area in 3 areas; prevention, detection and treatment.
QuestCap has a team of renowned global medical and business advisors who have developed a patented business strategy to capitalize on high-margin opportunities in THE COVID-19 space. This panel includes eminent immunologists, Dr. Lawrence Steinman and Dr. Glenn Copeland, who have forty-five years of experience in orthopedic treatment, foot and ankle care and sports medicine.
The main objective of QuestCap is the sale of FDA-approved COVID-19 IgG/IgM antibody controls as a U. S. component for use through authorized laboratories. This is achieved in a giant component through two acquisitions: one hundred percent of collection sites, LLC and 28%. Sanaty IPS. Collection sites established a number of COVID-19 verification sites in the United States, appointments and invoices will be processed through the online portal www. checkbeforeyougo. com. Sanaty is establishing a number of full-service medical clinics providing a complete COVID-19 verification solution.
For information, contact:
Doug Sommerville, CEODoug. Sommerville@questcapinc. com+1 416-301-5418
For requests, please contact: Evan Veryard Evan. veryard@questcapinc. com
For U. S. media inquiries, contact: Veronica Welchveronica@vewprmedia. com 1-508-643-8000
Caution related to forward-looking information
This press release comprises “forward-looking data” within the meaning of applicable Canadian securities law. Forward-looking data includes, but is not limited to, statements relating to the agreement between Collection Sites LLC and Simons; the proposed deployment of control sites; the term to verify the effects; projected source of check income; searching through QuestCap for investment opportunities; and the possible benefits or returns of those investments. In general, forward-looking data can be learned by using forward-looking terms such as “plans”, “expected” or “not expected”, “expected”, “budget”, “planned” “matrix estimates”, “anticipated” , “intends”, “anticipates” or “does not foresee”, or “believes”, or diversifications of those words and expressions or implies that certain actions, occasions or effects “possibly”, “may also simply”, “would be”, ” you can also simply “or” will be taken, “will happen”, or “will be accomplished. ” Forward-looking data is subject to known and unknown risks, insecurities and other points that would possibly cause the Company’s actual effects, point of activity, functionality or achievements, as the case may be, to differ materially from those expressed or implicit through this prospective data. Although the company has tried to identify vital points that may also cause the actual effects to differ materially from those contained in the forward-looking data, it is possible that there are other points that cause the effects to be other than expected, estimated, or planned. No guarantee can be given that such data will turn out to be accurate, as actual effects and long-term occasions may also differ materially from those expected in such statements. Consequently, readers deserve not to place undue reliance on forward-looking data. The Company does not adopt updating forward-looking data in accordance with applicable securities laws.
Neither THE CANADIAN STOCK EXCHANGE NOR ITS REGULATORY SERVICE PROVIDER HAS BEEN REVIEWED OR ACCEPTS LIABILITY FOR THE FITNESS OR ACCURACY OF THIS RELEASE.